These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 11485646)
1. Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence? Mooi FR; van Loo IH; King AJ Emerg Infect Dis; 2001; 7(3 Suppl):526-8. PubMed ID: 11485646 [TBL] [Abstract][Full Text] [Related]
2. Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. Bart MJ; Harris SR; Advani A; Arakawa Y; Bottero D; Bouchez V; Cassiday PK; Chiang CS; Dalby T; Fry NK; Gaillard ME; van Gent M; Guiso N; Hallander HO; Harvill ET; He Q; van der Heide HG; Heuvelman K; Hozbor DF; Kamachi K; Karataev GI; Lan R; Lutyńska A; Maharjan RP; Mertsola J; Miyamura T; Octavia S; Preston A; Quail MA; Sintchenko V; Stefanelli P; Tondella ML; Tsang RS; Xu Y; Yao SM; Zhang S; Parkhill J; Mooi FR mBio; 2014 Apr; 5(2):e01074. PubMed ID: 24757216 [TBL] [Abstract][Full Text] [Related]
3. Do we need a new vaccine to control the re-emergence of pertussis? Mills KH; Ross PJ; Allen AC; Wilk MM Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284 [TBL] [Abstract][Full Text] [Related]
4. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Mooi FR Infect Genet Evol; 2010 Jan; 10(1):36-49. PubMed ID: 19879977 [TBL] [Abstract][Full Text] [Related]
5. Re-emergence of pertussis: what are the solutions? Libster R; Edwards KM Expert Rev Vaccines; 2012 Nov; 11(11):1331-46. PubMed ID: 23249233 [TBL] [Abstract][Full Text] [Related]
6. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines. Hegerle N; Guiso N Expert Rev Vaccines; 2014 Sep; 13(9):1135-46. PubMed ID: 24953157 [TBL] [Abstract][Full Text] [Related]
7. The role of B. pertussis vaccine antigen gene variants in pertussis resurgence and possible consequences for vaccine development. Preston A Hum Vaccin Immunother; 2016 May; 12(5):1274-6. PubMed ID: 26889694 [TBL] [Abstract][Full Text] [Related]
8. Pertussis: pertussis control strategies and the options for improving current vaccines. Plotkin SA Expert Rev Vaccines; 2014 Sep; 13(9):1071-2. PubMed ID: 25090359 [TBL] [Abstract][Full Text] [Related]
9. Small mutations in Bordetella pertussis are associated with selective sweeps. van Gent M; Bart MJ; van der Heide HG; Heuvelman KJ; Mooi FR PLoS One; 2012; 7(9):e46407. PubMed ID: 23029513 [TBL] [Abstract][Full Text] [Related]
11. Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Mooi FR; van Loo IH; van Gent M; He Q; Bart MJ; Heuvelman KJ; de Greeff SC; Diavatopoulos D; Teunis P; Nagelkerke N; Mertsola J Emerg Infect Dis; 2009 Aug; 15(8):1206-13. PubMed ID: 19751581 [TBL] [Abstract][Full Text] [Related]
12. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years. Weber C; Boursaux-Eude C; Coralie G; Caro V; Guiso N J Clin Microbiol; 2001 Dec; 39(12):4396-403. PubMed ID: 11724851 [TBL] [Abstract][Full Text] [Related]
13. Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough. Bouchez V; Guiso N Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26242280 [TBL] [Abstract][Full Text] [Related]
14. Genetic Variation of Bordetella pertussis in Austria. Wagner B; Melzer H; Freymüller G; Stumvoll S; Rendi-Wagner P; Paulke-Korinek M; Repa A; Mooi FR; Kollaritsch H; Mittermayer H; Kessler HH; Stanek G; Steinborn R; Duchêne M; Wiedermann U PLoS One; 2015; 10(7):e0132623. PubMed ID: 26182210 [TBL] [Abstract][Full Text] [Related]
15. Changes in the Dutch Bordetella pertussis population in the first 20 years after the introduction of whole-cell vaccines. van Loo IHM; Mooi FR Microbiology (Reading); 2002 Jul; 148(Pt 7):2011-2018. PubMed ID: 12101289 [TBL] [Abstract][Full Text] [Related]
16. Analysis of Bordetella pertussis populations in European countries with different vaccination policies. van Amersfoorth SC; Schouls LM; van der Heide HG; Advani A; Hallander HO; Bondeson K; von König CH; Riffelmann M; Vahrenholz C; Guiso N; Caro V; Njamkepo E; He Q; Mertsola J; Mooi FR J Clin Microbiol; 2005 Jun; 43(6):2837-43. PubMed ID: 15956406 [TBL] [Abstract][Full Text] [Related]
17. [Molecular genetic characteristics of the B. pertussis strains isolated in different periods of the pertussis epidemic process]. Mazurova IK; Borisova OIu; Kombarova SIu; Zakharova NS; Aleshkin VA Mol Gen Mikrobiol Virusol; 2005; (4):21-5. PubMed ID: 16334221 [TBL] [Abstract][Full Text] [Related]
18. Resurgence of pertussis calls for re-evaluation of pertussis animal models. van der Ark AA; Hozbor DF; Boog CJ; Metz B; van den Dobbelsteen GP; van Els CA Expert Rev Vaccines; 2012 Sep; 11(9):1121-37. PubMed ID: 23151168 [TBL] [Abstract][Full Text] [Related]
19. Are vaccination programs and isolate polymorphism linked to pertussis re-emergence? Godfroid F; Denoël P; Poolman J Expert Rev Vaccines; 2005 Oct; 4(5):757-78. PubMed ID: 16221076 [TBL] [Abstract][Full Text] [Related]
20. Pertussis: challenges today and for the future. Cherry JD PLoS Pathog; 2013; 9(7):e1003418. PubMed ID: 23935481 [No Abstract] [Full Text] [Related] [Next] [New Search]